In the following subsections, we will focus on the most relevant studies regarding relaxin-2 circulatory levels in different backgrounds of CVDs, especially in HF, AF, ischemic heart disease, MI, aortic valve disease, hypertension, and atherosclerosis. This evidence concerns the gene RLN2 and aortic valve disorder.